FEB 21, 2020 5:49 PM PST

Understanding cancer heterogeneity

A team of researchers from Cornell has taken an innovative approach to crack the diversity code of cancer cells. Using a statistical modeling technique more commonly used in physics and economics, the researchers were able to show how cancer cells are influenced by their chemical environment. Their research was published in a study entitled "Lymphoidal Chemokine CCL19 Promoted the Heterogeneity of the Breast Tumor Cell Motility Within a 3D Microenvironment Revealed by a Lévy Distribution Analysis," in Integrative Biology.

One of the reasons that cancers are so hard to treat is because they come in so many forms and it is difficult to pin down which cells are the most detrimental. This phenomenon is referred to as diversity, or heterogeneity, of cancer cells.

"It's pretty tough to treat cancer. A lot of people in the field believe that is because of the diversity in the cancer population," said senior author Mingming Wu, professor of biological and environmental engineering in the College of Agriculture and Life Sciences. "It is similar to how we as a society are trying to make the population more diverse because we know that if the population is diverse, it's more robust, healthier," Wu said. "I think that cancer is the same way. They are making their population more diverse, more indestructible.

"While immune cells are rounded and kind of similar and move in the same way, cancer cells are different in shape and move at a different speed. We know that fast-movers are very lethal. How would you quantify that heterogeneity?"

To answer this question the team developed a microfluidic chip with 4 three-channel devices in which they placed breast tumor cells and the chemokine protein CCL19. They then monitored how each cancer cell behaved using open-source software Root and a high-tech statistical tool typically used in particle physics.

Co-author Anders Ryd explained, "What we do in particle physics is really statistical data analysis, trying to figure out what functional forms describe our data," said Ryd, who is a professor of physics in the College of Arts and Sciences. "And in this case here, the interest was to look at the outliers, the cells that migrated further and characterize that. A lot of the tools that we are using in particle physics lend themselves very well to this analysis."

With this statistical tool, the researchers discovered that the presence of chemokine made targeted cancer cells move more quickly, thus increasing heterogeneity. The authors say this pairing of different scientific fields is extremely helpful. "There are a lot of tools in physical science already, because physical science has always been a very quantitative field," Wu said. "It's only recently that quantitative biology is starting to shape up. So, I feel like this integration is powerful because you don't have to reinvent the wheel to do this modeling."

Sources: Integrative Biology, Science Daily

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
APR 27, 2020
Cancer
The Tumor Suppressor and its Regulator: An Indirect Oncogene
APR 27, 2020
The Tumor Suppressor and its Regulator: An Indirect Oncogene
Oncogenes, mutations in genes that promote cancer growth, have long been easy targets for cancer research due to the dir ...
MAY 04, 2020
Cancer
A Retroactive Study Finds an Immunotherapy Effective as a Third-Line Therapy
MAY 04, 2020
A Retroactive Study Finds an Immunotherapy Effective as a Third-Line Therapy
Cancer is a particularly persistent disease. Many therapies are composed of one or more different treatments. These trea ...
JUN 08, 2020
Cell & Molecular Biology
How Cancer Cells Use Inflammation as a Shield Against Viruses
JUN 08, 2020
How Cancer Cells Use Inflammation as a Shield Against Viruses
Microorganisms called oncolytic viruses can infect and kill cancer cells while leaving healthy cells alone.
JUN 08, 2020
Cancer
Using Soft Tissue Sarcoma's Immune Defense as a Biomarker
JUN 08, 2020
Using Soft Tissue Sarcoma's Immune Defense as a Biomarker
Programmed cell death protein 1 (PD-1) has been a big player in the treatment of both autoimmune disease and cancer. PD- ...
JUN 09, 2020
Cancer
Genetic counseling for prostate cancer testing goes telehealth
JUN 09, 2020
Genetic counseling for prostate cancer testing goes telehealth
Genetic testing for prostate cancer in men is not yet commonplace, despite the positive impact that it could have on dec ...
JUN 23, 2020
Cancer
Why are certain people more vulnerable to carcinogens?
JUN 23, 2020
Why are certain people more vulnerable to carcinogens?
A study from the University of Hawaii Cancer Center entitled, "Tumour predisposition and cancer syndromes as models ...
Loading Comments...